✦ LIBER ✦

Scleroderma and sclerotic skin conditions: unapproved treatments

✍ Scribed by Stefania Jablonska; Maria Blaszczyk

Book ID: 117564711
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 76 KB
Volume: 20
Category: Article
ISSN: 0738-081X
DOI: 10.1016/s0738-081x(02)00283-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Skin neoplasias including cutaneous lymp

Skin neoplasias including cutaneous lymphoma, melanoma, and others: unapproved treatments or indications

✍ Elizabeth A Abel 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Effectiveness, side-effects and period o

Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study

✍ E.B.M. Kroft; M.C.W. Creemers; F.H.J. Van Den Hoogen; J.B.M. Boezeman; E.M.G.J. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

Animal Model of Sclerotic Skin Induced b

Animal Model of Sclerotic Skin Induced by Bleomycin: A Clue to the Pathogenesis of and Therapy for Scleroderma?

✍ Toshiyuki Yamamoto 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Skin collagen from scleroderma patients

Skin collagen from scleroderma patients before and after cyclosporin A treatment

✍ C. FRANCÉS; M. C. BRANCHET; O. BLÉTRY; CH. LEFEVRE; S. BOISNIC; P. KERN; P. GODE 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Validity, reliability, and feasibility o

Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial

✍ Merkel, Peter A. ;Silliman, Nancy P. ;Denton, Christopher P. ;Furst, Daniel E. ; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 1 views

## Abstract ## Objective To determine the validity, reliability, and feasibility of durometer measurements of skin hardness as an outcome measure in clinical trials of scleroderma. ## Methods Skin hardness was measured during a multicenter treatment trial for scleroderma using handheld digital d

Intravenous immunoglobulin treatment rec

Intravenous immunoglobulin treatment recovers the down-regulated levels of Th1 cytokines in the sera and skin of scleroderma patients

✍ Kudo, Hideo; Jinnin, Masatoshi; Yamane, Keitaro; Makino, Takamitsu; Kajihara, Ik 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 582 KB